ARCHIVES

P-32 Ingestion At NCI Attracts Attention; Similar Cases Seen At Labs In The Past

This article is from The Cancer Letter archive.

Vol. 21 No. 42 | November 3, 1995

Download PDF Visit The Full Archive

Related Articles

NCAB Working Group To Hold Open And Closed Sessions

January 20, 1995

FDA Backs Down, Releases INDs, But Revives Controversy Over Clinical Testing Guidelines

March 12, 1976

For NCI ; Scharff Succeeds Eagle At Einstein

September 25, 1987

Congress Close to Approving Appropriations for FY 1985

September 14, 1984

Toxicity, Non-Cancer Deaths Increase With Combo Therapy

July 30, 2010

In Brief: O’Conor Names NCI Liaison To IARC, Saunders Acting IA Director Susan Sieber DCCP Deputy

May 27, 1983